Biomarker Pharmaceuticals Inc is categorized under Commercial Biotechnical Research in San Jose, CA and active since 2002.
Biomarker Pharmaceuticals Inc was established in 2002, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Xi Zhao-Wilson at the company’s single location by writing to 5941 Optical Court, San Jose, California CA 95138 or by phoning (408) 257-2000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Biomarker Pharmaceuticals Inc |
| Contact Person: | Xi Zhao-Wilson |
| Address: | 5941 Optical Court, San Jose, California 95138 |
| Phone Number: | (408) 257-2000 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Biomarker Pharmaceuticals Inc was started in 2002 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Xi Zhao-Wilson for inquiries that concern Biomarker Pharmaceuticals Inc by calling the company number (408) 257-2000, as your correspondence is most welcome. Additionally, the physical location of the single location of Biomarker Pharmaceuticals Inc can be found at the coordinates 37.254767,-121.784654 as well as the street address 5941 Optical Court in San Jose, California 95138.
For its online presence, you may visit Biomarker Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.